Eplerenone
Brand names,
Eplerenone
Analogs
Eplerenone
Brand Names Mixture
Eplerenone
Chemical_Formula
C24H30O6
Eplerenone
RX_link
http://www.rxlist.com/cgi/generic/inspra.htm
Eplerenone
fda sheet
Eplerenone
msds (material safety sheet)
Eplerenone
Synthesis Reference
No information avaliable
Eplerenone
Molecular Weight
414.491 g/mol
Eplerenone
Melting Point
No information avaliable
Eplerenone
H2O Solubility
Slightly soluble
Eplerenone
State
Solid
Eplerenone
LogP
2.445
Eplerenone
Dosage Forms
Tablet (film-coated - 25, 50 mg)
Eplerenone
Indication
For improvement of survival of stable patients with left ventricular systolic dysfunction (ejection fraction <40%) and clinical evidence of congestive heart failure after an acute myocardial infarction.
Eplerenone
Pharmacology
Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.
Eplerenone
Absorption
The absolute bioavailability of eplerenone is unknown.
Eplerenone
side effects and Toxicity
The most likely symptoms of human overdosage would be anticipated to be hypotension or hyperkalemia. However, no cases of human overdosage with eplerenone have been reported.
Eplerenone
Patient Information
Eplerenone
Organisms Affected
Humans and other mammals